ARDX - Ardelyx, Inc.
NEXT EARNINGS:
Apr 30, 2026
EPS Est: $-0.13
|
Rev Est: $95.9M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$17.00
DETAILS
HIGH:
$19.00
LOW:
$15.00
MEDIAN:
$17.00
CONSENSUS:
$17.00
UPSIDE:
159.15%
Market Cap:
1.59B
Volume:
8,624,598
Avg Volume:
4,111,366
52 Week Range:
3.21-8.4
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.58
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
395
IPO Date:
2014-06-19
EPS (TTM):
-0.26
P/E Ratio:
-22.81
Revenue (TTM):
407.32M
Total Assets:
501.60M
Total Debt:
211.59M
Cash & Equiv:
68.00M
Rev Growth (5Y):
121.9%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-9.9%
Debt/Equity:
1.27
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-19 | $-0.00 | $0.02 | -108.4% | $125.2M | $107.2M | +16.8% |
| 2025-10-30 | $-0.00 | $-0.06 | +93.3% | $110.3M | $119.1M | -7.3% |
| 2025-08-04 | $-0.08 | $-0.13 | +38.5% | $97.7M | $94.6M | +3.2% |
| 2025-05-01 | $-0.17 | $-0.10 | -70.0% | $74.1M | $79.4M | -6.7% |
| 2025-02-20 | $0.02 | $0.02 | 0.0% | $116.1M | $74.5M | +55.8% |
| 2024-10-31 | $-0.00 | $-0.05 | +93.1% | $98.2M | $108.6M | -9.5% |
| 2024-08-01 | $-0.07 | $-0.10 | +30.0% | $73.2M | $55.0M | +33.1% |
| 2024-05-02 | $-0.11 | $-0.13 | +15.4% | $46.0M | $36.4M | +26.4% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 407.32M | 333.62M | 124.46M | 52.16M | 10.10M | 7.57M | 5.28M | 2.61M | 42.00M | 24.03M | 24.03M | 31.62M |
| Net Income | (61.60M) | (39.14M) | (66.07M) | (67.21M) | (158.16M) | (94.31M) | (94.94M) | (91.30M) | (64.34M) | (112.39M) | (29.62M) | (3.21M) |
| EPS | -0.26 | -0.17 | -0.30 | -0.42 | -1.52 | -1.05 | -1.47 | -1.62 | -1.36 | -2.80 | -1.29 | -0.17 |
| Total Assets | 501.60M | 435.75M | 297.58M | 190.07M | 149.91M | 201.56M | 259.78M | 183.33M | 157.90M | 213.13M | 116.95M | 113.41M |
| Total Debt | 211.59M | 153.44M | 55.98M | 36.46M | 45.50M | 55.44M | 57.31M | 49.21M | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 68.00M | 64.93M | 21.47M | 96.14M | 72.43M | 91.03M | 181.13M | 78.77M | 75.38M | 74.60M | 107.00M | 107.29M |
| Operating Cash Flow | (42.48M) | (44.81M) | (89.72M) | (70.04M) | (152.55M) | (81.44M) | (76.48M) | (70.27M) | (65.19M) | (92.53M) | (71.84M) | 13.40M |
| Free Cash Flow | (43.98M) | (45.82M) | (90.06M) | (70.10M) | (154.42M) | (81.76M) | (76.81M) | (70.58M) | (67.55M) | (97.40M) | (75.29M) | 11.54M |
| FCF per Share | -0.18 | -0.19 | -0.41 | -0.44 | -1.48 | -0.91 | -1.19 | -1.26 | -1.42 | -2.43 | -3.29 | 0.62 |
| Book Value | 166.95M | 173.29M | 166.82M | 98.33M | 82.62M | 126.11M | 186.66M | 115.81M | 139.31M | 193.15M | 108.90M | 60.68M |
| Cash & ST Investments | 264.69M | 250.10M | 184.30M | 123.91M | 116.69M | 186.48M | 247.51M | 168.09M | 133.98M | 200.82M | 107.00M | 107.29M |
| ROC Equity | -0.37 | -0.23 | -0.40 | -0.68 | -1.91 | -0.75 | -0.51 | -0.79 | -0.46 | -0.58 | -0.27 | -0.05 |